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Abstract. Etoposide (ETP) treatment of ataxia telangi-
ectasia mutated (ATM) and Rad3-related protein (ATR)-, 
topoisomerase-binding protein-1 (TopBP1) and human MutY 
homolog (hMYH)‑depleted cells results in a significant reduc-
tion in apoptotic signaling. The association between ATR or 
TopBP1 and hMYH increased following ETP treatment. In 
hMYH knockdown cells, the interaction between ATR and 
TopBP1 decreased following ETP treatment. We suggest that 
hMYH functions as a sensor of ETP-induced apoptosis. The 
results suggest that in the absence of hMYH, cells are unable 
to recognize the damage signal and the ATR pathway is not 
activated.
Introduction
DNA damage response is essential for the maintenance of 
genome integrity (1-5). As a complex, the DNA damage 
response involves the recognition of DNA damage, activation 
of DNA damage‑responsive protein kinases, signal amplifi-
cation by downstream protein kinases and activation of the 
effector proteins that trigger various cellular processes. At low 
DNA damage levels, activation of the DNA damage response 
results in cell cycle arrest and DNA repair. However, at higher 
levels or under severe conditions, DNA damage response 
signaling frequently results in cell death by apoptosis (1-5).
Phosphoinositide 3-kinase-related protein kinases, ataxia 
telangiectasia mutated proteins (ATM) and Rad3-related 
proteins (ATR), are the key regulators of the DNA damage 
response (1-8). Once activated, ATM and ATR regulate 
an array of substrates, including Chk1 and Chk2, which 
culminate in DNA repair, cell cycle arrest and/or apoptosis. 
In the canonical model, ATR activation involves the recruit-
ment of the ATR-ATR interacting protein (ATR-ATRIP) and 
Rad9-Hus1-Rad1 (9-1-1) protein complexes to the DNA damage 
site via replication protein A (RPA). As a result, the 9-1-1 
complex brings topoisomerase-binding protein-1 (TopBP1) 
(ATR activator) close to ATR for ATR activation (1,4,8). 
Mammalian TopBP1 functions at the DNA replication check-
point (9,10) and has multiple BRCA1 C-terminal (BRCT) 
repeats, which usually function in tandem to bind phosphopro-
teins (11,12). TopBP1 colocalizes with ATR-ATRIP at the sites 
of DNA replication stress (9,10). The N-terminus of TopBP1 
is required for its recruitment and the resulting activation of 
ATR via interaction with Rad9 in mammalian cells (13).
Human MutY homolog (hMYH) is a base excision repair 
DNA glycosylase that excises misincorporated adenine 
opposite 7,8-dihydro-8-oxoguanine (8-oxoG), a product of 
oxidative DNA damage. Furthermore, in hMYH-disrupted 
cells, the phosphorylation of ATR and Chk1 is decreased by 
hydroxyurea (HU) or ultraviolet (UV) treatment (14). The 
hMYH is known to interact with 9-1-1 (15), and a recent study 
revealed that it also interacts with ATR and MutS α via the 
human MutS homolog (hMSH) 6 subunit (14,16).
The mismatch repair protein hMSH2 may interact with 
ATR and participate in ATR activation during DNA damage, 
leading to apoptosis. Therefore, hMSH2‑deficient cells are 
more resistant to apoptosis (17). The mismatch repair and 
MYH repair pathways share many common features. First, 
both pathways function immediately following DNA replica-
tion to distinguish newly synthesized DNA strands from their 
parental counterparts (18,19). Second, hMYH and hMSH6 
interact with the replication proteins proliferating cell nuclear 
antigen and RPA and colocalize at the same replication 
foci (20,21). Finally, both pathways are involved in mutation 
avoidance following DNA oxidation. Therefore, we suggest 
that the interaction between hMYH and hATR is the same as 
hMSH2 and hATR.
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Etoposide (ETP), a topoisomerase II inhibitor, is known 
to induce apoptosis and activate ATR via TopBP1 (22,23); 
however, it is unclear how hMYH is involved during the ETP 
response. In this study, MYH, ATR and TopBP1 knockdown 
cells were treated with ETP. In the absence of these proteins, 
the cells were more resistant to ETP-induced apoptosis. 
We determined for the first time that hMYH interacts with 
hTopBP1 or hATR in HEK293 cells, and that this interaction 
is increased following ETP treatment. However, when hMYH 
is disrupted, the interaction between hATR and hTopBP1 is 
decreased following ETP treatment. Since hATR is inactive, 
the apoptosis signal cannot transduce to the downstream 
proteins, specifically p‑Chk2 and p‑p53.
Materials and methods
Cell lines. Human embryonic kidney HEK293 cells were 
grown in Dulbecco's modified Eagle's medium (Invitrogen 
Life Technologies, Carlsbad, CA, USA) supplemented with 
10% fetal bovine serum (Invitrogen Life Technologies) and 
1% penicillin-streptomycin solution (Sigma, St. Louis, MO, 
USA) at 37˚C in a 5% CO2 incubator. Prior to the experiments, 
HEK293 cells were seeded into 6-well plates at a density of 
1x106 cells per well and incubated for 24 h.
siRNA construction and transfection into cells. The optimum 
siRNA sequences for the knockdown of endogenous hMYH 
were designed and purchased from the Stealth™ RNAi 
program of Invitrogen Life Technologies. siRNA corre-
sponding to nucleotides 415‑439 of the green fluorescence 
protein (GFP) was used as a negative control. The siMYH and 
siGFP sequences and transfection method were conducted as 
previously described (14). ATR siRNA (sc-29763) and TopBP1 
siRNA were purchased from Santa Cruz Biotechnology, 
Inc. (sc-41068; Santa Cruz, CA, USA). ATR and TopBP1 
knockdown were conducted according to the manufacturer's 
instructions.
Protein extraction and western blot analysis. HEK293 cells 
were harvested, washed with phosphate-buffered saline 
(PBS) and lysed with lysis buffer containing 50 mM Tris-HCl 
phenylmethanesulfonylfluoride, protease and a phosphatase 
inhibitor cocktail (Sigma), for 1 h at 4˚C with occasional 
vortexing. Protein extracts were collected following centrifu-
gation at 16,000 x g for 20 min, and protein concentration was 
determined using a Bio-Rad DC protein assay kit (Bio-Rad, 
Hercules, CA, USA). Protein extracts that were resolved on 
8 or 12% sodium dodecyl sulfate (SDS)-polyacrylamide gels 
were transferred onto PVDF membranes (GE Healthcare 
Worldwide, Princeton, NJ, USA). The membranes were 
blocked with 5% non-fat dried milk in Tris-buffered saline with 
0.05% Tween-20 and then incubated with antibodies against 
ATR, Chk1, Chk2, phospho-Chk1 (Ser-345), phospho-Chk2 
(Thr-68), β-actin (all from Santa Cruz Biotechnology, Inc.), 
phospho-ATR (Ser-428), caspase 9, caspase 7, p-p53 (Ser-15; 
all from Cell Signaling Technology, Inc., Beverly, MA, USA), 
TopBP1 (Abcam, Cambridge, UK) and hMYH (Abnova, 
Teipei, Taiwan). Membranes were then incubated with horse-
radish peroxidase-conjugated secondary antibodies (Santa 
Cruz Biotechnology, Inc.). Protein bands were detected using 
enhanced chemiluminescence (ECL) Pico western blotting 
detection reagents (Pierce Biotechnology, Inc., Rockford, IL, 
USA).
Immunofluorescence microscopy. To determine the subcel-
lular location of ATR, TopBP1 and hMYH, HEK293 cells 
were seeded onto polylysine-coated coverslips and treated with 
25 µM ETP for 48 h. At room temperature, cells were fixed 
with 4% paraformaldehyde in PBS for 30 min and permea-
bilized with 0.25% Triton X-100 in PBS for 30 min. After 
blocking with 1% bovine serum albumin in PBS containing 
0.5% Tween-20 (PBS-T) for 30 min, cells were incubated with 
ATR (1:100; Santa Cruz Biotechnology, Inc.), TopBP1 (1:500; 
Abcam) and MYH monoclonal antibodies (1:100; Abnova) for 
2 h. The cells were washed 3 times for 15 min each in PBS 
and incubated with Alexa 488-conjugated anti-mouse IgG 
(1:100; Sigma), fluorescein isothiocyanate (FITC)‑conjugated 
anti-rabbit IgG (1:100; Sigma) for 2 h. Cells were rinsed 3 times 
with 1 ml PBS and analyzed using a confocal fluorescence 
microscope (Olympus FV-1000; software, Olympus Fluoview; 
Olympus, Center Valley, PA, USA).
Co‑immunoprecipitation. Co-immunoprecipitation (IP) of 
endogenous proteins using an ATR antibody was conducted 
using the ImmunoCruz™ IP/WB Optima B System (Santa 
Cruz Biotechnology, Inc.) according to the manufacturer's 
instructions. IP was conducted using rabbit anti-ATR, and 
immunoblot (IB) analysis was conducted using rabbit 
anti-ATR, rabbit anti-TopBP1 and mouse anti-MYH. To 
determine the effect of ETP on MYH-ATR and MYH-TopBP1 
interaction, a similar co-IP procedure was conducted using 
mouse anti-MYH for co-IP, and IB analysis using rabbit 
anti-ATR, rabbit anti-TopBP1 and mouse anti-MYH.
Statistical analysis. Experiments were conducted in triplicate 
and statistical analyses were conducted using the Student's 
t-test. Data are expressed as the mean, and P<0.05 was consid-
ered to indicate a statistically significant difference.
Results
Effect of ETP on HEK293 cell proliferation. We examined the 
effect of ETP on cell viability by treating cells with 3 different 
concentrations of ETP (10, 25 and 50 µM) for various periods 
of time. After 24, 48 and 72 h of treatment, cell viability was 
determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyltetrazolium bromide (MTT) assay. Fig. 1A shows that 
treatment with ETP greatly reduced cell viability compared 
with the control cells. ETP induced apoptosis in HEK293 
cells in a time- and dose-dependent manner. We determined 
that treatment with 25 µM ETP was the best condition for our 
subsequent experiments.
To assess the molecular mechanism of ETP-induced 
apoptosis, we examined the expression of the 85-kDa cleaved 
form of poly-ADP ribose polymerase (PARP), an apoptosis 
marker, and hMYH, an apoptosis-related protein (25). Cells 
were treated with 25 µM ETP for 24, 48 or 72 h. As shown in 
Fig. 1B, cleavage of PARP was observed after 48 and 72 h. The 
hMYH protein level increased in a time-dependent manner, 
indicating the involvement of hMYH in apoptosis. Taken 
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together, treatment with 25 µM ETP for 48 h was the best 
condition for the subsequent experiment.
To further determine the effect of hMYH on cell viability, 
cells transfected with MYH-siRNA or control-siRNA were 
treated with 25 µM ETP for 48 h. Fig. 1C shows that cell 
viability, as determined by the MTT assay, decreased by 
~40% in the control cells, while only a 17% decrease was 
observed in MYH-siRNA cells. These results suggested the 
involvement of hMYH in apoptotic signaling during ETP 
treatment.
hMYH, hTopBP1 and hATR deficient cells are resistant to 
ETP‑induced apoptosis and DNA‑damage signaling. Recently, 
it has been reported that ATR phosphorylation upon HU or UV 
treatment was decreased in hMYH-disrupted HEK293 and 
HaCaT cells (14). ATR is known to phosphorylate Chk1 and 
Chk2 (14,15), and here, we observed a phosphorylation of Chk2 
only in control-transfected cells, but not in siMYH cells following 
ETP treatment (Fig. 2A). This result suggests that hMYH is 
required for ATR-mediated Chk2 activation under these condi-
tions. The phosphorylation of Chk1 observed was similar to 
Figure 2. MYH, ATR and TopBP1 knockdown decreases ETP-induced apoptosis in HEK293 cells. (A) MYH knockdown reduces the activation of apop-
tosis-related proteins. Control or siMYH transfected cells were treated with 25 µM ETP for 48 h. Total cell lysates were used for IB analysis of p-Chk2 
(threonine-68), p-p53 (threonine-15), caspase 9, caspase 7 and MYH. β-actin was used as a loading control. (B and C) The same experiment as in A, however, 
the cells were transfected with siRNA for either ATR or TopBP1. IB, immunoblot; MYH, MutY homolog; PARP, poly-ADP ribose polymerase; Cas, caspase; 
GFP, green fluorescence protein; ETP, etoposide; ATR, Rad3‑related protein; TopBP1, topoisomerase‑binding protein‑1.
  A   B   C
Figure 1. ETP-induced apoptosis in HEK293 cells. (A) ETP treatment reduced cell viability. Cells were treated with 0, 10, 25 and 50 µM ETP. After 24, 
48 and 72 h, 20 µl MTT was added to each well and incubated for an additional 4 h. The results shown are the mean ± SD of 3 independent experiments. 
(B) ETP-induced cleavage of PARP following 48 h of incubation. Cells were incubated with 25 µM ETP for 24, 48 and 72 h. Cell lysates were subjected to 
SDS-PAGE. PARP and MYH expression levels were determined by western blotting using the indicated antibodies. (C) hMYH knockdown reduced cell 
viability following ETP treatment. Cells were transfected with siGFP or siMYH and incubated for 24 h. Cells were then treated with 25 µM ETP for 48 h. 
Cell viability was determined by the MTT assay. The results shown are the mean ± SD of 3 independent experiments. ETP, etoposide; IB, immunoblot; PARP, 
poly‑ADP ribose polymerase; MYH, MutY homolog; GFP, green fluorescence protein. MTT, 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide; 
SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; hMYH, human MYH.
  A   B
  C
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that of Chk2 (data not shown). Since transactivation of proapop-
totic proteins through the p53-dependent signaling pathway 
is an important apoptotic mechanism, we focused on Chk2 
because of its involvement in p53 regulation and ETP-induced 
apoptosis (22,24). As shown in Fig. 2A, ETP-induced p53 phos-
phorylation was abrogated in siMYH-transfected cells.
Caspase is a well-known key molecule in DNA 
damage-induced apoptosis (22). The activation of caspase 9 
and caspase 7 was examined via western blot analysis in 
hMYH knockdown and control cells. ETP treatment induced 
the cleavage of inactive 47-kDa procaspase 9 into smaller, 
detectable, active 37-kDa fragments, and the cleavage of 
inactive 32-kDa procaspase 7 into the 20-kDa active form in 
control cells (Fig. 2A). However, the active forms of caspase 9 
and 7 were not detected in hMYH knockdown cells following 
ETP treatment.
To determine the role of ATR relative to Chk2 or p53 in 
ETP-induced apoptosis, cells were treated with either control 
or ATR siRNA for 24 h, and then treated with ETP for 48 h. 
We observed increased phosphorylation or activation of Chk2 
and p53 in control siRNA-transfected cells (Fig. 2B). However, 
the active forms of caspase 9 and 7 were not observed in hATR 
knockdown cells.
Since hTopBP1 is known to activate hATR, we observed 
the apoptosis pattern in hTopBP1 knockdown cells. Fig. 2C 
shows that apoptosis was decreased in hTopBP1 knockdown 
cells in comparison to the control cells, and similar results 
were observed in hMYH and hATR knockdown cells.
hMYH associates with ATR or TopBP1 in HEK293 cells during 
ETP treatment. ETP treatment activated hATR, hTopBP1 and 
hMYH (A-T-M), which triggered a signaling cascade leading 
to apoptosis. However, it is unclear how A-T-M is activated and 
regulates the apoptosis pathway. To determine whether hMYH 
regulates hATR or hTopBP1 in DNA damage models, we 
conducted a co-IP assay to confirm that hMYH interacts with 
hATR or hTopBP1. Cells were treated with 25 µM ETP for 
48 h, and whole cell extracts were used. As shown in Fig. 3A, 
ETP treatment induced the association of hMYH-hATR and 
hMYH-hTopBP1. Our results suggest that hMYH interacts 
with hATR or hTopBP1 and participates in A-T-M activa-
tion during ETP treatment, which leads to the DNA damage 
response and signals apoptosis.
A critical function of hATR or hTopBP1 activation during 
genotoxic stress is the accumulation of hATR or hTopBP1 in 
the nucleus, where signaling proteins form multiple nuclei and 
interact in response to DNA damage (6,11). To examine the 
changes in hATR and hTopBP1 localization, we conducted 
immunofluorescence (IF) experiments. We treated cells with 
25 µM ETP for 48 h, and conducted IF assays to determine 
whether hMYH and hATR or hTopBP1 occupied the same 
subcellular locations during genotoxic stress. In untreated 
control cells, light hMYH staining was observed in the 
cytoplasm (Fig. 3B). However, following ETP treatment, we 
observed a higher intensity hMYH staining that translocated 
to the nucleus, indicating an increased expression. Staining 
of hATR and hTopBP1, which are known to localize to the 
nucleus, also increased in intensity following ETP treatment. 
Superimposition of hMYH‑dependent green fluorescence with 
hATR or hTopBP1‑dependent yellow fluorescence resulted in 
yellow‑green images in cells. Topro3 Red (red fluorescence) is 
a nuclear marker. These results are consistent with the interac-
tion of hMYH with hTopBP1 or hATR and their colocalization 
in cells.
Figure 3. Interaction of MYH with ATR or TopBP1 increased following ETP treatment. (A) ATR or TopBP1 interact with MYH increases following treatment 
with ETP. Cells were treated with 25 µM ETP for 48 h. Cells were lysed and total cell lysates were used for co-IP with MYH antibody. IP samples were analyzed 
by western blotting with ATR or TopBP1 and MYH antibodies. β-actin was used as a loading control. (B) ATR or TopBP1 and MYH co-localized following 
treatment with ETP. Cells were cultured overnight on coverglass bottom dishes, then treated with 25 µM ETP for 48 h, and fixed with 4% paraformaldehyde 
and permeabilized with 0.1% Triton X-100 in PBS. Cells were then stained with antibodies against ATR or TopBP1 (FITC; yellow), MYH (Alexa®488/Green) 
and To-pro®3 (Red). IB, immunoblot; ATR, Rad3-related protein; TopBP1, topoisomerase-binding protein-1; MYH, MutY homolog; IP, immunoprecipitation; 
Ab, antibody. ETP, etoposide; PBS, phosphate‑buffered saline; FITC, fluorescein isothiocyanate. 
  A
  B
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ATR and TopBP1 interaction decreased in hMYH‑deficient 
cells during ETP treatment. The decrease in hMYH expres-
sion results in decreased apoptotic signaling following ETP 
treatment (Fig. 2A). Furthermore, hMYH interacts with 
hATR or hTopBP1 and this interaction increased following 
treatment with ETP (Fig. 3A). To observe the implication 
of hATR, hTopBP1 and hMYH interaction in this pathway, 
we conducted co-IP assays using ATR antibody. Cells were 
transfected with siGFP, as a control, or siMYH. Then, cells 
were treated with or without ETP. Total cell lysates were 
used in co-IP, and the presence of A-T-M was observed using 
western blot analysis.
A decreased hMYH expression was observed in MYH 
knockdown cells (Fig. 4A), while changes in ATR and TopBP1 
expression levels were not observed in MYH knockdown 
cells. Following treatment with ETP, the expression of A-T-M 
increased. Furthermore, the co-IP result suggests that the 
interaction between hATR and hTopBP1 was decreased in 
MYH knockdown cells following treatment with ETP.
Discussion
hMYH interacts not only with hATR, but also with the 
human MutS homologs (hMSH2/hMSH6) via the hMSH6 
subunit (14,16). hMSH2 directly participates in ATR recruit-
ment and activation, leading to DNA damage signaling and 
subsequent apoptosis. Therefore, hMSH2 deficiency increases 
the resistance of cells to apoptosis (17). Another study suggests 
that the nuclear isoforms of hMYH initiate cell death by 
sensing adenine opposite 8-oxoG during nuclear DNA replica-
tion, thus suppressing tumorigenesis. In addition, accumulation 
of 8-oxoG in mitochondrial DNA and initiation cell death by 
MYH may also contribute to the tumor suppression (25).
In this study, we implicated the DNA glycosylase, hMYH, in 
ETP-induced apoptosis, and revealed that hMYH knockdown 
cells reduce Chk2 (T-68) and p53 (T-15) phosphorylation. We 
also observed similar results in ATR and TopBP1 knockdown 
cells (Fig. 2). This result suggests the possibility that hATR, 
hTopBP1 and hMYH (A-T-M) function in the same pathway. 
This was accompanied by the suppression of proapoptotic 
protein expression and decreased apoptosis. The interaction 
between hMYH with ATR and TopBP1 is dependent on ETP 
treatment (Fig. 3).
In hMYH knockdown cells, ATR and TopBP1 interaction 
decreases following ETP treatment (Fig. 4A). We suggest that 
hMYH functions as a sensor in ETP induced apoptosis. In the 
absence of hMYH, cells cannot recognize the damage signal, 
and thus the ATR pathway is not activated, which results in 
tumor development (14,25).
Based on these observations, we suggest new pathways for 
A-T-M sensor activation (Fig. 4B). This pathway is initiated by 
MYH, which recruits and activates ATR-related proteins in 
ETP-induced apoptosis. In summary, binding of MYH directly 
participates in ATR and TopBP1 activation in DNA damage 
signaling, leading to apoptosis. An MYH protein deficiency 
increases the resistance of cells to apoptosis.
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